Rogaczewska M, Stopa M. Intravitreal clindamycin in the treatment of ocular toxoplasmosis: a report of two cases. Klinika Oczna / Acta Ophthalmologica Polonica. 2021;123(1):42-45. doi:10.5114/ko.2021.104752.
APA
Rogaczewska, M., & Stopa, M. (2021). Intravitreal clindamycin in the treatment of ocular toxoplasmosis: a report of two cases. Klinika Oczna / Acta Ophthalmologica Polonica, 123(1), 42-45. https://doi.org/10.5114/ko.2021.104752
Chicago
Rogaczewska, Małgorzata, and Marcin Stopa. 2021. "Intravitreal clindamycin in the treatment of ocular toxoplasmosis: a report of two cases". Klinika Oczna / Acta Ophthalmologica Polonica 123 (1): 42-45. doi:10.5114/ko.2021.104752.
Harvard
Rogaczewska, M., and Stopa, M. (2021). Intravitreal clindamycin in the treatment of ocular toxoplasmosis: a report of two cases. Klinika Oczna / Acta Ophthalmologica Polonica, 123(1), pp.42-45. https://doi.org/10.5114/ko.2021.104752
MLA
Rogaczewska, Małgorzata et al. "Intravitreal clindamycin in the treatment of ocular toxoplasmosis: a report of two cases." Klinika Oczna / Acta Ophthalmologica Polonica, vol. 123, no. 1, 2021, pp. 42-45. doi:10.5114/ko.2021.104752.
Vancouver
Rogaczewska M, Stopa M. Intravitreal clindamycin in the treatment of ocular toxoplasmosis: a report of two cases. Klinika Oczna / Acta Ophthalmologica Polonica. 2021;123(1):42-45. doi:10.5114/ko.2021.104752.
